InvestorsHub Logo
icon url

CA$H I$ KING

10/01/18 6:34 PM

#85255 RE: handMMJ #85250

Our president has put the " right to try" into law! You know where we are adults and if we want it we can try it!!
icon url

wrinklesobw

10/01/18 6:41 PM

#85267 RE: handMMJ #85250

In the past the failure to get it fda approved as a class two device is because they had no data, reason why they decided to start testing on animals and collect data. FDA veterinary has classified it as a class two device. I’m sure with all the data they have now, the fda will give them the green light to start human testing. Also remember class 2 device requires less testing and can usually be done in about 9months pending on fda protocols.
icon url

JohnnyRothrock

10/01/18 10:47 PM

#85462 RE: handMMJ #85250

RDGL is becoming a powerhouse pet/cancer biotech, with its 2018 trackrecord of 100% cured cancer in 5 cats and a dog, documented and treated at Washington State University and University of Missouri, with state of the art labs and teams.

-i think what we are all missing here, is if human trails never even happened, well look at the above! And horses they said are next. So cornering the market in types of cancer cures are you kidding me we are two cent stock? Anyone please show me a $10 or $50 biotech who can factual claim the same.

But RDGL all along plans to then enter human trials.. But just as an animal/pet cancer curing company, well the valuations are extraordinary here in all ways from .02 to who knows how high to me. Everything else becomes extreme bonus.

-and best of all no more FDA approval needed for these animal procedures we are good to go and in last PR even the University of Missouri Veternairy Oncologists are already recommending the IsoPet treatment woooooooooo!